CoCensys

CoCensys of Irvine, CA is a biopharmaceutical company that discovers and develops products for the treatment of neurological and psychiatric disorders. The company's product development programs focus on novel small molecule compounds for the treatment of epilepsy, anxiety, Parkinson's and other neurodegenerative diseases, neuropathic pain, migraine, insomnia and stroke. CoCensys has development programs with the Wyeth-Ayerst Laboratories Division of American Home Products Corporation to develop analogs of naturally-occurring neuroactive compounds, ``epalons,'' for the treatment of anxiety, with Parke-Davis Pharmaceutical Division of Warner-Lambert Company to identify and develop subtype-selective NMDA receptor antagonists for the treatment of a variety of neurological and psychiatric diseases, and with Senju Pharmaceutical and Parke-Davis for the exploration of ophthalmic indications of CoCensys' glutamate receptor antagonist compounds.

Previous Forums
Date/Time		Forum
Mar 13 1999		Fourth San Diego Biotech Stocks Forum
Mar 4 1999		Atlanta Health Care Stocks Forum

Market Assistant		PrecisionAlert
This company has no data		Enter your email address to receive alerts about this company